Paclitaxel-Kimia

• An anthracycline mechanism which intercalates into DNA and inhibits topoisomerase II, promoting the generation of free radicals that induce tumor cell death. • Demonstrates a longstanding, evidence-based role in treating breast cancer, lymphomas, sarcomas, and other malignancies. • Delivered via IV in...

• An anthracycline derivative which intercalates into DNA and inhibits topoisomerase II, disrupting cancer cell replication. • Demonstrated success in the treatment of breast and other solid tumors through extensive clinical trials. • Delivered via infusion, integrating smoothly into established chemoth...

• Gemcitabine functions as a nucleoside analog that, once activated, impedes DNA synthesis and triggers tumor cell death. • Its therapeutic use is well-established in treating a range of malignancies, including pancreatic, lung, and breast cancers. • The drug is administered through intravenous infusion...

• Inhibits topoisomerase I to interfere with DNA replication and trigger tumor cell apoptosis. • Clinically validated through extensive studies in metastatic colorectal and other solid tumors. • Delivered via intravenous infusion to integrate seamlessly with established chemotherapy regimens. • Demonst...

• Inhibits dihydrofolate reductase to block folate metabolism and impede DNA synthesis. • Provides rapid therapeutic effects through intravenous, intramuscular, intra-arterial injection. • Widely used in oncology and autoimmune therapies to manage various conditions. • Proven to induce remission a...

• Platinum-based compound that forms DNA cross-links to disrupt cancer cell replication. • Clinically proven in colorectal and gastrointestinal malignancies through robust trials. • Administered via intravenous infusion, fitting into established chemotherapy regimens such as FOLFOX. • Clinical studies ...

• Fluorouracil disrupts DNA synthesis by inhibiting thymidylate synthase, impairing tumor cell proliferation. • Proven efficacy across multiple cancers, including colorectal and breast malignancies, through comprehensive clinical studies. • Primarily administered via intravenous infusion. • Demonstrate...

• High-purity active pharmaceutical ingredient formulated for the production of abiraterone acetate dosage forms. • Effectively inhibits CYP17, contributing to reduced androgen synthesis in prostate cancer therapies. • Presented as a white to off-white crystalline powder that meets strict quality standa...

• High-purity active pharmaceutical ingredient designed for the manufacture of dasatinib-based formulations. • A potent multi-targeted tyrosine kinase inhibitor effective against BCR-ABL and Src family kinases. • Exhibits robust inhibitory activity, making it a critical component in treatments for CML a...

• High-quality active pharmaceutical ingredient used in the manufacture of non-sedating antihistamine formulations. • Manufactured under strict cGMP standards to ensure exceptional consistency and purity. • Offered as a fine, crystalline powder with excellent physicochemical stability. • Complies with ...

• High-purity active pharmaceutical ingredient developed for erlotinib-based formulations. • Potent inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, essential for targeting aberrant cancer cell signaling. • Supplied as a fine crystalline powder with excellent physicochemical sta...

• High-quality active pharmaceutical ingredient developed for fingolimod-based formulations. • Potent modulator of sphingosine-1-phosphate receptors, crucial for managing relapsing multiple sclerosis. • Manufactured under strict cGMP conditions to ensure consistent quality and batch-to-batch reproducibi...